What is REGENERAR’s goal?

REGENERAR is harnessing the development of the non-viral formulation will take in account the contributes of key stakeholders in the area of gene editing, health institutions, patient associations, among others.

Improving the Effectiveness and Safety of Cell
Reprogramming in Brain Regeneration

About the project

Brain injuries are a significant cause of mortality and morbidity across the world. The outcome of brain injuries is cell death, with high chances of functional and cognitive limitations, such as movement deficits, mood disorders, headaches, disturbances of memory, emotion, and behaviour, and increased risk of development of neurodegenerative diseases. Bain has a limited capacity to repair itself and technologies to replace lost neurons after an injury are of great need.

REGENERAR is a Horizon Europe-funded project that brings together six partners from three European countries who will work together for four years to REGENERAR aims to revolutionize the treatment of neurological disorders and promote brain repair.






Total Budget

48 months

Project Duration

March 1, 2024

Start Date

News & Events